MedPath

Nina Hermans

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

2 Phases

Phase 3:1
Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (66.7%)
Phase 3
1 (33.3%)

Extracts of Amla, Walnut Leaf, Red Yeast Rice and Olive in Cardiovascular Prevention

Phase 4
Completed
Conditions
Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
First Posted Date
2024-03-27
Last Posted Date
2024-11-14
Lead Sponsor
Nina Hermans
Target Recruit Count
36
Registration Number
NCT06333158
Locations
🇧🇪

UAntwerp, NatuRAPT, Wilrijk, Antwerp, Belgium

Olive Polyphenols in Cardiovascular Prevention

Phase 4
Completed
Conditions
Hypertension, Systolic
First Posted Date
2021-05-06
Last Posted Date
2024-11-15
Lead Sponsor
Nina Hermans
Target Recruit Count
56
Registration Number
NCT04874961
Locations
🇧🇪

UAntwerp, NatuRAPT, Wilrijk, Belgium

Effect of Pycnogenol® on ADHD

Phase 3
Completed
Conditions
ADHD
Interventions
Dietary Supplement: Pycnogenol
Other: Placebo
First Posted Date
2016-03-07
Last Posted Date
2021-04-28
Lead Sponsor
Nina Hermans
Target Recruit Count
88
Registration Number
NCT02700685
Locations
🇧🇪

Universitaire Kinder- en Jeugdpsychiatrie, Borgerhout, Belgium

🇧🇪

University Hospital Antwerp, Edegem, Belgium

🇧🇪

University Hospital Ghent, Ghent, Belgium

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.